Create issue ticket

4,425 Possible Causes for Parkinson's Disease, Progressive Disease

  • Progressive Supranuclear Palsy

    The current gold standard for measuring clinical disease progression in PSP is the PSP Rating Scale score.[] P/M, pons to midbrain ratio; PD, idiopathic Parkinson's disease; PSP-RS, Progressive Supranuclear Palsy-Richardson's Syndrome; Parkinson's disease; Progressive Supranuclear[] The ability to assess the distribution and extent of tau pathology in Alzheimer's disease and progressive supranuclear palsy in vivo would help to develop biomarkers for these[]

  • Amyotrophic Lateral Sclerosis

    This review examined current research related to moderate exercise for maintaining independence without accelerating disease progression in persons with ALS.[] Amyotrophic lateral sclerosis (ALS) and Parkinson's disease, both progressive neurodegenerative diseases, affect 1 million Americans (1,2).[] PMID: 19556916 Issn Print: 1557-0576 Publication Date: 2009/06/01 Checking for direct PDF access through Ovid Abstract Amyotrophic lateral sclerosis (ALS) is an idiopathic disease[]

  • Alzheimer Disease

    BACKGROUND AND OBJECTIVE: Semantic memory measures may be useful in tracking and predicting progression of Alzheimer disease.[] Parkinson's Disease Rating Scale; MMSE: Mini-Mental State Examination; PD: Parkinson disease; PDD: Parkinson disease dementia.[] Alzheimer’s is a progressive disease. This means that gradually, over time, more parts of the brain are damaged.[]

  • Classic Progressive Supranuclear Palsy Syndrome

    Not Applicable tideglusib;tideglusib;placebo 44 Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy Completed NCT02734485 Not[] Neuropsychological characterization of typical and atypical progressive supranuclear palsy and comparison with Parkinson's disease.[] A whole-brain analysis in de novo Parkinson disease. Am. J.[]

  • Young-Onset Parkinson Disease

    YOPD has a slower disease progression and a greater incidence and earlier appearance of levodopa-induced motor complications; namely, motor fluctuations and dyskinesias.[] Fourteen autobiographies written by individuals living with young-onset Parkinson's disease were also used as data sources.[] Parkinson’s treatment aims to slow the disease’s progression.[]

  • Parkinson's Disease

    This study assessed the effect of levodopa on the rate of progression of Parkinson's disease.[] So far no laboratory tests exist for diagnosing Parkinson's disease.[] Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL-PET study.[]

  • Parkinson's Disease Type 3

    However, symptoms vary and may worsen as the disease progresses.[] Parkinson's disease type 3 (PD3) is a form of Parkinson's disease that is inherited in an autosomal dominant manner.[] It tends to be less responsive to typical Parkinson’s disease medication especially as it progresses.[]

  • Parkinson-Dementia Syndrome

    Parkinson's disease is progressive: It gets worse over time.[] Murat Emre OUP Oxford, ٠٨‏/٠١‏/٢٠١٥ - 320 من الصفحات In this edited volume, experts on the treatment of dementia associated with Parkinson's Disease (PD) describe in detail[] disease, dementia associated with Parkinson disease, dementia in Parkinson disease, and dementia with parkinsonism.[]

  • Degenerative Brain Disorder

    "This is a rapidly progressing disease, so any drug that could slow down the degenerative process would give people the option to live longer."[] Can Phosphatidylserine Fight Parkinson's Disease? The researchers believe that phosphatidylserine could help treat other neurodegenerative diseases, like Parkinson's.[] progression.3-5With markers of clinical disease progression integral to the measurement of efficacy of disease-modifying therapies, a team of investigators led by Professor[]

  • Striatonigral Degeneration

    The performance of patients with SND was also compared with that of 14 patients with Parkinson's disease and 14 patients with progressive supranuclear palsy (PSP) matched[] Calcineurin immunoreactivity was densely distributed throughout the substantia nigra of patients with Parkinson's disease and control subjects.[] progression are unclear.[]

Further symptoms

Similar symptoms